Science

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

Malak Alharbi/LinkedIn

Feb 22, 2025, 16:00

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

Malak Alharbi, PGY6 hematology oncology fellow at Roswell Park Comprehensive Cancer Center, shared an article on LinkedIn:

“Happy to share our recent publication on a case highlighting the diagnostic challenges at presentation and the therapeutic complexities of treating PRCA secondary to SMM.

We discuss the appropriate workup and explore daratumumab as a potential management option for these patients.

Thank you Dr Hillengass Jens for your support and mentorship!”

Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature.

Authors: Malak Alharbi, et al.

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

cancer Daratumumab fight against cancer Global fight against cancer Hillengass Jens Malak Alharbi multiple myeloma OncoDaily Oncology PRCA Roswell Park Comprehensive Cancer Center SMM

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity